Legal Opinion
Genetic Technologies Limited v. Merial L.L.C.
Court of Appeals for the Federal Circuit
Decided April 8, 2016No. 2015-1202, 2015-1203PublishedCited by 179 opinions
1Opinion of the Court
DYK, Circuit Judge.
Genetic Technologies Limited (“GTG”) brought suit against Merial L.L.C. (“Merial”) and Bristol-Myers Squibb (“BMS”) (together, “appellees”). GTG alleged that appellees had infringed U.S. Patent No. 5,612,179 (“the '179 patent”), which relates to methods of detecting genetic variations.' The district court granted appellees’ motions to dismiss for failure to state a claim and entered final judgment that claims 1-25 and 33-36 of the '179 patent are ineligible for patenting under 35 U.S.C. § 101. For purposes of this appeal, the parties have stipulated that claim 1 is…
2Cases cited14 opinions
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.Supreme Court of the United States · 2012
- Diamond v. DiehrSupreme Court of the United States · 1981
- Content Extraction & Transmission LLC v. Wells Fargo BankCourt of Appeals for the Federal Circuit · 2014
- Sands v. McCormickCourt of Appeals for the Third Circuit · 2007
- Gottschalk v. BensonSupreme Court of the United States · 1972
9 more not listed; retrieve them via the Exa API.
3Cited by179 opinions
- Enfish, LLC v. Microsoft CorporationCourt of Appeals for the Federal Circuit · 2016
- Electric Power Group, LLC v. Alstom S.A.Court of Appeals for the Federal Circuit · 2016
- Aatrix Software, Inc. v. Green Shades Software, Inc.Court of Appeals for the Federal Circuit · 2018
- Affinity Labs of Texas, LLC v. Directv, LLCCourt of Appeals for the Federal Circuit · 2016
- SAP Am., Inc. v. InvestPic, LLCCourt of Appeals for the Federal Circuit · 2018
174 more not listed; retrieve them via the Exa API.